Great Valley Advisor Group, Inc. Biocryst Pharmaceuticals Inc Transaction History
Great Valley Advisor Group, Inc.
- $3.45 Billion
- Q2 2024
A detailed history of Great Valley Advisor Group, Inc. transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Great Valley Advisor Group, Inc. holds 16,400 shares of BCRX stock, worth $124,148. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,400
Previous 17,400
5.75%
Holding current value
$124,148
Previous $88,000
14.77%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding BCRX
# of Institutions
258Shares Held
173MCall Options Held
397KPut Options Held
444K-
Black Rock Inc. New York, NY20MShares$151 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.8MShares$142 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.6MShares$95.2 Million1.06% of portfolio
-
State Street Corp Boston, MA9.35MShares$70.8 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.83MShares$66.8 Million4.25% of portfolio
About BIOCRYST PHARMACEUTICALS INC
- Ticker BCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,944,992
- Market Cap $1.41B
- Description
- BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...